Ouchen Wang

3.3k total citations
101 papers, 2.3k citations indexed

About

Ouchen Wang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Ouchen Wang has authored 101 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 35 papers in Endocrinology, Diabetes and Metabolism and 35 papers in Cancer Research. Recurrent topics in Ouchen Wang's work include Thyroid Cancer Diagnosis and Treatment (34 papers), Cancer-related molecular mechanisms research (19 papers) and RNA modifications and cancer (15 papers). Ouchen Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (34 papers), Cancer-related molecular mechanisms research (19 papers) and RNA modifications and cancer (15 papers). Ouchen Wang collaborates with scholars based in China, United States and Nepal. Ouchen Wang's co-authors include Xiaohua Zhang, Erjie Xia, Adheesh Bhandari, Xuanxuan Dai, Fan Yang, Siyang Dong, Xiaohua Zhang, Yili Zhou, Yehuan Liu and Xiaoqu Hu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ouchen Wang

99 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ouchen Wang China 28 1.3k 841 558 455 315 101 2.3k
Hung‐Ming Lam United States 24 1.1k 0.9× 494 0.6× 677 1.2× 770 1.7× 315 1.0× 57 2.5k
Junichi Inokuchi Japan 28 1.1k 0.9× 533 0.6× 254 0.5× 478 1.1× 401 1.3× 161 2.4k
Haiyong Wang China 27 867 0.7× 477 0.6× 180 0.3× 550 1.2× 327 1.0× 83 1.8k
Bingyin Shi China 25 1.1k 0.9× 355 0.4× 460 0.8× 342 0.8× 190 0.6× 87 1.9k
Marialuisa Sponziello Italy 22 707 0.6× 338 0.4× 1.1k 1.9× 302 0.7× 303 1.0× 67 1.8k
Myriem Boufraqech United States 23 1.1k 0.8× 540 0.6× 450 0.8× 366 0.8× 186 0.6× 45 1.8k
Eiji Kashiwagi Japan 31 1.3k 1.0× 588 0.7× 203 0.4× 628 1.4× 565 1.8× 126 2.6k
Shiu‐Ru Lin Taiwan 32 1.1k 0.8× 818 1.0× 209 0.4× 1.1k 2.5× 358 1.1× 105 2.7k
Naveen Vasudev United Kingdom 22 903 0.7× 384 0.5× 132 0.2× 380 0.8× 251 0.8× 70 1.8k
Chunyan Gu China 24 1.5k 1.2× 678 0.8× 227 0.4× 295 0.6× 368 1.2× 93 2.3k

Countries citing papers authored by Ouchen Wang

Since Specialization
Citations

This map shows the geographic impact of Ouchen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ouchen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ouchen Wang more than expected).

Fields of papers citing papers by Ouchen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ouchen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ouchen Wang. The network helps show where Ouchen Wang may publish in the future.

Co-authorship network of co-authors of Ouchen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ouchen Wang. A scholar is included among the top collaborators of Ouchen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ouchen Wang. Ouchen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dai, Juji, Weicheng Liang, Lin Ye, et al.. (2023). PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. Cell Death and Disease. 14(6). 373–373. 5 indexed citations
4.
Hu, Chunlei, Hao Chen, Yinghao Wang, et al.. (2023). LINC00891 Promotes Tumorigenesis and Metastasis of ThyroidCancer by Regulating SMAD2/3 via EZH2. Current Medicinal Chemistry. 31(24). 3818–3833. 2 indexed citations
5.
6.
Hu, Chunlei, et al.. (2022). Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis. Future Oncology. 22(5). 553–566. 3 indexed citations
7.
Mao, Xiaoyun, Pengwei Lv, Yiping Gong, et al.. (2022). Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis. Frontiers in Oncology. 12. 855512–855512. 8 indexed citations
8.
Zheng, Chen, et al.. (2020). Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition. Cell Biochemistry and Function. 38(2). 158–166. 5 indexed citations
9.
Wang, Yinghao, et al.. (2019). The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Human Cell. 32(3). 334–342. 26 indexed citations
10.
Zhou, Yuying, et al.. (2019). LRRC52‐AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer. Clinical and Experimental Pharmacology and Physiology. 47(4). 696–702. 5 indexed citations
11.
Bhandari, Adheesh, et al.. (2019). lncRNA FOXD3‐AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer. Cell Biochemistry and Function. 37(4). 239–244. 27 indexed citations
12.
Wang, Yinghao, et al.. (2019). IGSF1: A novel oncogene regulates the thyroid cancer progression. Cell Biochemistry and Function. 37(7). 516–524. 11 indexed citations
13.
Yin, Changtian, Xuanxuan Dai, Xiangjie Huang, et al.. (2019). Alantolactone promotes ER stress‐mediated apoptosis by inhibition of TrxR1 in triple‐negative breast cancer cell lines and in a mouse model. Journal of Cellular and Molecular Medicine. 23(3). 2194–2206. 32 indexed citations
14.
Jiang, Yang, Yuefeng Li, Yefeng Cai, et al.. (2019). METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition. Journal of Molecular Endocrinology. 63(1). 51–61. 30 indexed citations
15.
Zhou, Xiaofen, Yingying Chen, Yinghao Wang, et al.. (2019). Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma. Journal of Cancer. 10(15). 3543–3552. 6 indexed citations
16.
Zhou, Xiaofen, Qingxuan Wang, Xiaohua Zhang, et al.. (2018). Clinical effect of <em>MUC1</em> and its relevance to <em>BRAF</em> V600E mutation in papillary thyroid carcinoma: a case&ndash;control study. Cancer Management and Research. Volume 10. 1351–1358. 4 indexed citations
17.
18.
Yang, Fan, Lin Lv, Siyang Dong, et al.. (2016). Identification of lncRNA<em> FAM83H-AS1</em> as a novel prognostic marker in luminal subtype breast cancer. OncoTargets and Therapy. Volume 9. 7039–7045. 38 indexed citations
19.
Wang, Ouchen, et al.. (2015). Unexpected features of breast cancer subtype. World Journal of Surgical Oncology. 13(1). 249–249. 5 indexed citations
20.
Ye, Lechi, Ouchen Wang, Guanli Huang, et al.. (2015). IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population. OncoTargets and Therapy. 8. 1493–1493. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hung‐Ming Lam Breakdown of academic impact, for papers by Junichi Inokuchi Breakdown of academic impact, for papers by Haiyong Wang Breakdown of academic impact, for papers by Bingyin Shi Breakdown of academic impact, for papers by Marialuisa Sponziello Breakdown of academic impact, for papers by Myriem Boufraqech Breakdown of academic impact, for papers by Eiji Kashiwagi Breakdown of academic impact, for papers by Shiu‐Ru Lin Breakdown of academic impact, for papers by Naveen Vasudev Breakdown of academic impact, for papers by Chunyan Gu
Rankless by CCL
2026